Mycobacterium marinum: a potential immunotherapy for Mycobacterium tuberculosis infection

References

• Glaziou P Floyd K Raviglione M Global burden and epidemiology of tuberculosis Clin Chest Med 2009 30 4 621 636 19925958
   PubMed Web of Science ®Google Scholar
• Bourinbaiar AS Mezentseva M V Butov DA Immune approaches in tuberculosis therapy: a brief overview Expert Rev Anti Infect Ther 2012 10 3 381 389 22397570
   PubMed Web of Science ®Google Scholar
• Orme IM Development of new vaccines and drugs for TB: limitations and potential strategic errors Future Microbiol 2011 6 2 161 177 21366417
   PubMed Web of Science ®Google Scholar
• Elsabahy M Wooley KL Design of polymeric nanoparticles for biomedical delivery applications Chem Soc Rev 2012 41 7 2545 2561 22334259
   PubMed Web of Science ®Google Scholar
• Gupta A Ahmad FJ Ahmad F Efficacy of Mycobacterium indicus pranii immunotherapy as an adjunct to chemotherapy for tuberculosis and underlying immune responses in the lung PLoS One 2012 7 7 e39215 22844392
   PubMed Web of Science ®Google Scholar
• Mayosi BM Ntsekhe M Bosch J Rationale and design of the Investigation of the Management of Pericarditis (IMPI) trial: a 2 × 2 factorial randomized double-blind multicenter trial of adjunctive prednisolone and Mycobacterium w immunotherapy in tuberculous pericarditis Am Heart J 2013 165 2 109 115 23351812
   PubMed Web of Science ®Google Scholar
• Kawai K Miyazaki J Joraku A Nishiyama H Akaza H Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: current understanding and perspectives on engineered BCG vaccine Cancer Sci 2013 104 1 22 27 23181987
   PubMed Web of Science ®Google Scholar
• Rich FJ Kuhn S Hyde EJ Harper JL Ronchese F Kirman JR Induction of T cell responses and recruitment of an inflammatory dendritic cell subset following tumor immunotherapy with Mycobacterium smegmatis Cancer Immunol Immunother 2012 61 12 2333 2342 22714285
   PubMed Web of Science ®Google Scholar
• Fávaro WJ Nunes OS Seiva FR Effects of P-MAPA immunomodulator on toll-like receptors and p53: potential therapeutic strategies for infectious diseases and cancer Infect Agent Cancer 2012 7 1 14 22709446
   PubMed Web of Science ®Google Scholar
• Orme IM The Achilles heel of BCG Tuberculosis (Edinb) 2010 90 6 329 332 20659816
   PubMed Web of Science ®Google Scholar
• Kaufmann SH Fact and fiction in tuberculosis vaccine research: 10 years later Lancet Infect Dis 2011 11 8 633 640 21798463
   PubMed Web of Science ®Google Scholar
• Martin C The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG? Eur Respir J 2005 26 1 162 167 15994403
   PubMed Web of Science ®Google Scholar
• Slany M Jezek P Fiserova V Mycobacterium marinum infections in humans and tracing of its possible environmental sources Can J Microbiol 2012 58 1 39 44 22182182
   PubMed Web of Science ®Google Scholar
• Gordon S The macrophage: past, present and future Eur J Immunol 2007 37 Suppl 1 S9 S17 17972350
   PubMed Web of Science ®Google Scholar
• Peyron P Vaubourgeix J Poquet Y Foamy macrophages from tuberculous patients’ granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence PloS Pathog 2008 4 11 e1000204 19002241
   PubMed Web of Science ®Google Scholar
• Martinez FO Sica A Mantovani A Locati M Macrophage activation and polarization Front Biosci 2008 13 453 461 17981560
   PubMed Web of Science ®Google Scholar
• Mills CD Kincaid K Alt JM Heilman MJ Hill AM M-1/M-2 macrophages and the Th1/Th2 paradigm J Immunol 2000 164 12 6166 6173 10843666
   PubMed Web of Science ®Google Scholar
• Cooper AM Mayer-Barber KD Sher A Role of innate cytokines in mycobacterial infection Mucosal Immunol 2011 4 3 252 260 21430655
   PubMed Web of Science ®Google Scholar
• Zhu X W Friedland JS Multinucleate giant cells and the control of chemokine secretion in response to Mycobacterium tuberculosis Clin Immunol 2006 120 1 10 20 16504587
   PubMed Web of Science ®Google Scholar
• McElvania Tekippe E Allen IC Hulseberg PD Granuloma formation and host defense in chronic mycobacterium tuberculosis infection requires PYCARD/ASC but not NLRP3 or caspase-1 PloS One 2010 5 8 e12320 20808838
   PubMed Web of Science ®Google Scholar
• Price NM Gilman RH Uddin J Recavarren S Friedland JS Unopposed matrix metalloproteinase-9 expression in human tuberculous granuloma and the role of TNF-α-dependent monocyte networks J Immunol 2003 171 10 5579 5586 14607966
   PubMed Web of Science ®Google Scholar
• Makino M Baba M A cryopreservation method of human peripheral blood mononuclear cells for effcient production of dendritic cells Scand J Immunol 1997 45 6 618 622 9201301
   PubMed Web of Science ®Google Scholar
• Cassetta L Cassol E Poli G Macrophage polarization in health and disease Scientific World Journal 2011 11 2391 2402 22194670
   PubMed Web of Science ®Google Scholar
• Krausgruber T Blazek K Smallie T IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses Nat Immunol 2011 12 3 231 238 21240265
   PubMed Web of Science ®Google Scholar
• Gordon S Taylor PR Monocyte and macrophage heterogeneity Nat Rev Immunol 2005 5 12 953 964 16322748
   PubMed Web of Science ®Google Scholar
• Saunders BM Tran S Ruuls S Sedgwick JD Briscoe H Britton WJ Transmembrane TNF is sufficient to initiate cell migration and granuloma formation and provide acute, but not long-term, control of Mycobacterium tuberculosis infection J Immunol 2005 174 8 4852 4859 15814712
   PubMed Web of Science ®Google Scholar
• Olleros ML Guler R Vesin D Contribution of transmembrane tumor necrosis factor to host defense against Mycobacterium bovis bacillus Calmette-guerin and Mycobacterium tuberculosis infections Am J Pathol 2005 166 4 1109 1120 15793291
   PubMed Web of Science ®Google Scholar
• Manzanillo PS Shiloh MU Portnoy DA Cox JS Mycobacterium tuberculosis activates the DNA-dependent cytosolic surveillance pathway within macrophages Cell Host Microbe 2012 11 5 469 480 22607800
   PubMed Web of Science ®Google Scholar
• Mayer-Barber KD Barber DL Shenderov K Cutting edge: caspase-1 independent IL-1{beta} production is critical for host resistance to Mycobacterium tuberculosis and does not require TLR signaling in vivo J Immunol 2010 184 7 3326 3330 20200276
   PubMed Web of Science ®Google Scholar
• Bafica A Scanga CA Feng CG Leifer C Cheever A Sher A TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis J Exp Med 2007 202 12 1715 1724 16365150
   PubMed Web of Science ®Google Scholar
• Gerosa F Baldani-Guerra B Lyakh LA Differential regulation of interleukin 12 and interleukin production in human dendritic cells J Exp Med 2008 205 6 1447 1461 18490488
   PubMed Web of Science ®Google Scholar
• Hölscher C Atkinson RA Arendse B A protective and agonistic function of IL-12p40 in mycobacterial infection J Immunol 2001 167 12 6957 6966 11739515
   PubMed Web of Science ®Google Scholar
• Awomoyi AA Marchant A Howson JM McAdam KP Blackwell JM Newport MJ Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis J Infect Dis 2002 186 12 1808 1814 12447767
   PubMed Web of Science ®Google Scholar
• Beamer GL Flaherty DK Assogba BD Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J mice J Immunol 2008 181 8 5545 5550 18832712
   PubMed Web of Science ®Google Scholar
• Algood HM Lin PL Flynn JL Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis Clin Infect Dis 2005 41 Suppl 3 S189 S193 15983898
   PubMed Web of Science ®Google Scholar
• O’Kane CM Boyle JJ Horncastle DE Elkington PT Friedland JS Monocyte-dependent fibroblast CXCL8 secretion occurs in tuberculosis and limits survival of mycobacteria within macrophages J Immunol 2007 178 6 3767 3776 17339475
   PubMed Web of Science ®Google Scholar
• Hasan Z Jamil B Zaidi I Zafar S Khan AA Hussain R Elevated serum CCL2 concomitant with a reduced mycobacterium-induced response leads to disease dissemination in leprosy Scand J Immunol 2006 63 3 241 247 16499578
   PubMed Web of Science ®Google Scholar
• Ordway D Higgins DM Sanchez-Campillo J XCL1 (lymphotactin) chemokine produced by activated CD8 T cells during the chronic stage of infection with Mycobacterium tuberculosis negatively affects production of IFN-gamma by CD4 T cells and participates in granuloma stability J Leukoc Biol 2007 82 5 1221 1229 17699612
   PubMed Web of Science ®Google Scholar
• Chiu BC Freeman CM Stolberg VR Cytokine-chemokine networks in experimental mycobacterial and schistosomal pulmonary granuloma formation Am J Respir Cell Mol Biol 2003 29 1 106 116 12600821
   PubMed Web of Science ®Google Scholar
• Wang H Dong D Tang S Chen X Gao Q PPE38 of Mycobacterium marinum triggers the cross-talk of multiple pathways involved in the host response, as revealed by subcellular quantitative proteomics J Proteome Res 2013 12 5 2055 2066 23514422
   PubMed Web of Science ®Google Scholar